UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment

BMJ evidence-based medicine, 2019-10, Vol.24 (5), p.177

2019

Link zum Volltext

Verfügbarkeit prüfen

Activation of 5-HT6 receptors facilitates attentional set shifting

Psychopharmacologia, 2010-01, Vol.208 (1), p.13-21

2010

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2008-06, Vol.33 (7), p.1642-1652

2008

Link zum Volltext

Verfügbarkeit prüfen

A comparison of possible markers for chandelier cartridges in rat medial prefrontal cortex and hippocampus

Brain research, 2005-01, Vol.1031 (2), p.238-244

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices

Neuroscience letters, 1991-09, Vol.130 (1), p.107-111

1991

Link zum Volltext

Verfügbarkeit prüfen

The Nitric Oxide - Cyclic GMP Pathway and Synaptic Depression in Rat Hippocampal Slices

The European journal of neuroscience, 1994-10, Vol.6 (10), p.1528-1535

1994

Link zum Volltext

Verfügbarkeit prüfen

Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo

European journal of pharmacology, 2005-09, Vol.519 (3), p.237-245

2005

Link zum Volltext

Verfügbarkeit prüfen

GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models

The Journal of pharmacology and experimental therapeutics, 2007-06, Vol.321 (3), p.1032

2007

Link zum Volltext

Verfügbarkeit prüfen

Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one

Molecular pharmacology, 1995-08, Vol.48 (2), p.184-188

1995

Link zum Volltext

Verfügbarkeit prüfen

The nitric oxide-cyclic GMP signalling pathway in rat brain

Neuropharmacology, 1993-11, Vol.32 (11), p.1267-1277

1993

Link zum Volltext

Verfügbarkeit prüfen

Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040

Psychopharmacologia, 2009, Vol.201 (4), p.483-494

2009

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation

Synapse (New York, N.Y.), 2009-10, Vol.63 (10), p.836-846

2009

Link zum Volltext

Verfügbarkeit prüfen

Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats

Synapse (New York, N.Y.), 2008-08, Vol.62 (8), p.628-631

2008

Link zum Volltext

Verfügbarkeit prüfen

Reversal of isolation-rearing-induced PPI deficits by an alpha 7 nicotinic receptor agonist

Psychopharmacology, 2005-10, Vol.182 (2), p.214-219

2005

Link zum Volltext

Verfügbarkeit prüfen

Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist

Psychopharmacologia, 2005-10, Vol.182 (2), p.214-219

2005

Link zum Volltext

Verfügbarkeit prüfen

Activation of 5-HT sub(6) receptors facilitates attentional set shifting

Psychopharmacology, 2010-01, Vol.208 (1), p.13-21

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of the selective dopamine D 3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain

Brain research, 2007-05, Vol.1149, p.50-57

2007

Link zum Volltext

Verfügbarkeit prüfen

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

European journal of pharmacology, 1998-09, Vol.358 (1), p.19-24

1998

Link zum Volltext

Verfügbarkeit prüfen

Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain

Brain research, 2007-05, Vol.1149, p.50-57

2007

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

European journal of pharmacology, 2010-02, Vol.627 (1-3), p.106-114

2010

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo characterization of PheTQS, a novel α7 nAChR positive allosteric modulator

Biochemical pharmacology, 2009-10, Vol.78 (7), p.913-913

2009

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo comparison of two non-peptide tachykinin NK sub(3) receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

European journal of pharmacology, 2010-02, Vol.627 (1-3), p.106-114

2010

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo comparison of two non-peptide tachykinin NK 3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

European journal of pharmacology, 2010, Vol.627 (1), p.106-114

2010

Link zum Volltext

Verfügbarkeit prüfen

Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist

Psychopharmacology, 2005-10, Vol.182 (2), p.214-219

2005

Link zum Volltext

Verfügbarkeit prüfen

Reversal of isolation-rearing-induced PPI deficits by an [alpha]7 nicotinic receptor agonist

Psychopharmacology, 2005-10, Vol.182 (2), p.214

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(25)
Animals
(23)
Rats
(20)
Biological And Medical Sciences
(17)
Male
(17)
Neurosciences
(16)
Neurosciences & Neurology
(15)
Humans
(11)
Pharmacology & Pharmacy
(11)
Medical Sciences
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Cyclic Gmp
(7)
Cyclic Gmp - Metabolism
(7)
In Vitro Techniques
(7)
Rats, Wistar
(7)
Brain - Drug Effects
(6)
Dose-Response Relationship, Drug
(6)
Female
(6)
Nitric Oxide
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment

Activation of 5-HT6 receptors facilitates attentional set shifting

In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia

A comparison of possible markers for chandelier cartridges in rat medial prefrontal cortex and hippocampus

Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices

The Nitric Oxide - Cyclic GMP Pathway and Synaptic Depression in Rat Hippocampal Slices

Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo

GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models

Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one

The nitric oxide-cyclic GMP signalling pathway in rat brain

Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040

Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation

Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats

Reversal of isolation-rearing-induced PPI deficits by an alpha 7 nicotinic receptor agonist

Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist

Activation of 5-HT sub(6) receptors facilitates attentional set shifting

Effect of the selective dopamine D 3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain

In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

In vitro and in vivo characterization of PheTQS, a novel α7 nAChR positive allosteric modulator

In vitro and in vivo comparison of two non-peptide tachykinin NK sub(3) receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

In vitro and in vivo comparison of two non-peptide tachykinin NK 3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics

Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist

Reversal of isolation-rearing-induced PPI deficits by an [alpha]7 nicotinic receptor agonist

Suchergebnisse filtern